Evidence of improving antiretroviral therapy treatment delays: an analysis of eight years of programmatic outcomes in Blantyre, Malawi

Table 2 Univariate and multivariate associations with time from last positive HIV test and initiation of ART

Variable	GMR^±	95% CI^*	Adjusted GMR^±	95% CI^*	P
Sex
Men	1		1		0.007
Women	1.13	1.06-1.21	1.12	1.03-1.22
Age group
0-5 years	0.87	0.75-0.99	1.02	0.84-1.24	0.526
5-15 years	1.16	0.99-1.37	1.14	0.93-1.39
15-25 years	1.00	0.89-1.23	0.93	0.81-1.08
25-35 years	1		1
35-45 years	1.00	0.92-1.08	0.96	0.87-1.06
≥ 45 years	1.00	0.90-1.10	0.96	0.84-1.09
Site of HIV test
QECH	1		1
Facility other than QECH	1.65	1.54-1.77	1.61	1.47-1.77	<0.001
Unknown	1.82	1.64-2.02	1.93	1.66-2.24
WHO stage at registration
Stage 1 or 2	1
Stage 3 or 4	1.01	0.95-1.08
CD4 count (cells/μl)
≥ 350	1		1		<0.001
250 – 350	0.87	0.70-1.11	0.96	0.75-1.20
50 – 250	0.76	0.61-0.95	0.77	0.62-0.98
<50	0.50	0.40-0.63	0.53	0.42-0.68
Year of ART initiation
2004	0.92	0.75-1.14	0.79	0.52-1.21	0.004
2005	1		1
2006	0.72	0.60-0.87	0.75	0.48-1.16
2007	0.64	0.55-0.76	0.71	0.50-1.03
2008	0.68	0.59-0.80	0.72	0.51-1.02
2009	0.69	0.59-0.80	0.69	0.49-0.99
2010	0.75	0.64-0.88	0.85	0.60-1.21
2011	0.54	0.47-0.63	0.84	0.59-1.21
Number of ART initiators per year (continuous)	1.00	1.00-1.00

^±Bootstrapped estimates of geometric mean ratios, adjusted for sex, age group, site of HIV test, CD4 count strata and year of ART initiation.
^*Bias corrected accelerated 95% confidence intervals.
GMR Geometric mean ratio, CI confidence interval, QECH Queen Elizabeth Central Hospital.

ISSN: 1471-2458